Heart drug trial aims to stop dangerous Post-Surgery complication
NCT ID NCT06067438
Summary
This study is testing if a heart medication called amiodarone can prevent a common and serious irregular heartbeat (atrial fibrillation) after a specific type of esophageal cancer surgery. About 90 patients will be randomly assigned to receive either the real medication or a placebo (inactive substance) for one week after their operation. Researchers will track if the medication reduces the irregular heartbeat and other complications, aiming to establish a standard prevention method.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.